An Open-label Extension Phase of the Double-blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Studies to Evaluate the Efficacy and Safety of E2007(perampanel)Given as Adjunctive Therapy in Subjects with Refractory Partial Seizures

Grants and Contracts Details

StatusFinished
Effective start/end date5/8/09 → 10/31/14

Funding

  • Eisai Incorporated: $10,396.00